403 related articles for article (PubMed ID: 14630445)
1. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA.
Fogarty PF; Yamaguchi H; Wiestner A; Baerlocher GM; Sloand E; Zeng WS; Read EJ; Lansdorp PM; Young NS
Lancet; 2003 Nov; 362(9396):1628-30. PubMed ID: 14630445
[TBL] [Abstract][Full Text] [Related]
2. TERC mutations in children with refractory cytopenia.
Ortmann CA; Niemeyer CM; Wawer A; Ebell W; Baumann I; Kratz CP
Haematologica; 2006 May; 91(5):707-8. PubMed ID: 16670076
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
Vulliamy TJ; Walne A; Baskaradas A; Mason PJ; Marrone A; Dokal I
Blood Cells Mol Dis; 2005; 34(3):257-63. PubMed ID: 15885610
[TBL] [Abstract][Full Text] [Related]
4. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.
Vulliamy T; Marrone A; Szydlo R; Walne A; Mason PJ; Dokal I
Nat Genet; 2004 May; 36(5):447-9. PubMed ID: 15098033
[TBL] [Abstract][Full Text] [Related]
5. Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome.
Field JJ; Mason PJ; An P; Kasai Y; McLellan M; Jaeger S; Barnes YJ; King AA; Bessler M; Wilson DB
J Pediatr Hematol Oncol; 2006 Jul; 28(7):450-3. PubMed ID: 16825992
[TBL] [Abstract][Full Text] [Related]
6. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex.
Vulliamy TJ; Dokal I
Biochimie; 2008 Jan; 90(1):122-30. PubMed ID: 17825470
[TBL] [Abstract][Full Text] [Related]
7. Dyskeratosis congenita: its link to telomerase and aplastic anaemia.
Dokal I; Vulliamy T
Blood Rev; 2003 Dec; 17(4):217-25. PubMed ID: 14556776
[TBL] [Abstract][Full Text] [Related]
8. Dyskeratosis congenita and telomerase.
Bessler M; Wilson DB; Mason PJ
Curr Opin Pediatr; 2004 Feb; 16(1):23-8. PubMed ID: 14758110
[TBL] [Abstract][Full Text] [Related]
9. Association between aplastic anaemia and mutations in telomerase RNA.
Vulliamy T; Marrone A; Dokal I; Mason PJ
Lancet; 2002 Jun; 359(9324):2168-70. PubMed ID: 12090986
[TBL] [Abstract][Full Text] [Related]
10. Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome.
Yamaguchi H; Baerlocher GM; Lansdorp PM; Chanock SJ; Nunez O; Sloand E; Young NS
Blood; 2003 Aug; 102(3):916-8. PubMed ID: 12676774
[TBL] [Abstract][Full Text] [Related]
11. Stem cells, telomerase and dyskeratosis congenita.
Mason PJ
Bioessays; 2003 Feb; 25(2):126-33. PubMed ID: 12539238
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations.
Marrone A; Sokhal P; Walne A; Beswick R; Kirwan M; Killick S; Williams M; Marsh J; Vulliamy T; Dokal I
Haematologica; 2007 Aug; 92(8):1013-20. PubMed ID: 17640862
[TBL] [Abstract][Full Text] [Related]
13. Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita.
Ly H; Schertzer M; Jastaniah W; Davis J; Yong SL; Ouyang Q; Blackburn EH; Parslow TG; Lansdorp PM
Blood; 2005 Aug; 106(4):1246-52. PubMed ID: 15886322
[TBL] [Abstract][Full Text] [Related]
14. Mutations of telomerase complex genes linked to bone marrow failures.
Yamaguchi H
J Nippon Med Sch; 2007 Jun; 74(3):202-9. PubMed ID: 17625368
[TBL] [Abstract][Full Text] [Related]
15. Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency.
Marrone A; Stevens D; Vulliamy T; Dokal I; Mason PJ
Blood; 2004 Dec; 104(13):3936-42. PubMed ID: 15319288
[TBL] [Abstract][Full Text] [Related]
16. The effect of TERC haploinsufficiency on the inheritance of telomere length.
Goldman F; Bouarich R; Kulkarni S; Freeman S; Du HY; Harrington L; Mason PJ; Londoño-Vallejo A; Bessler M
Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17119-24. PubMed ID: 16284252
[TBL] [Abstract][Full Text] [Related]
17. Dyskeratosis congenita caused by a novel TERT point mutation in siblings with pancytopenia and exudative retinopathy.
Sharma A; Myers K; Ye Z; D'Orazio J
Pediatr Blood Cancer; 2014 Dec; 61(12):2302-4. PubMed ID: 25067791
[TBL] [Abstract][Full Text] [Related]
18. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita.
Vulliamy T; Marrone A; Goldman F; Dearlove A; Bessler M; Mason PJ; Dokal I
Nature; 2001 Sep; 413(6854):432-5. PubMed ID: 11574891
[TBL] [Abstract][Full Text] [Related]
19. Robust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells.
Pereboeva L; Hubbard M; Goldman FD; Westin ER
PLoS One; 2016; 11(2):e0148793. PubMed ID: 26859482
[TBL] [Abstract][Full Text] [Related]
20. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
Marrone A; Dokal I
Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
